openPR Logo
Press release

U.S. Ketamine Clinics Market: Key Players and Competitive Landscape 2023-2028

11-28-2023 11:43 AM CET | Health & Medicine

Press release from: IMARC Group

U.S. Ketamine Clinics Market

U.S. Ketamine Clinics Market

IMARC Group, a leading market research company, has recently releases report titled "U.S. Ketamine Clinics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the U.S. ketamine clinics market growth, trends, size, share and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big Is the U.S. Ketamine Clinics Market?

The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022 and is expected to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.

Request for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample

What are Ketamine Clinics?

Ketamine clinics are medical facilities that specialize in the administration of ketamine, a dissociative anesthetic, for therapeutic purposes. They offer a novel and rapidly effective treatment option for individuals who have not responded to traditional antidepressant medications. They are managed by medical professionals who are well-versed in administering the medication safely and monitoring patients during and after treatment, which ensures a high level of safety and reduces the risk of adverse effects. As they offer a convenient and safe environment while providing relief from various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD), the demand for ketamine clinics is rising in the U.S.

U.S. Ketamine Clinics Market Trends and Drivers:

At present, the growing demand for ketamine due to its effectiveness in providing rapid relief for treatment-resistant depression and other mental health conditions represents one of the key factors offering a favorable market outlook in the U.S. Besides this, the increasing demand for ketamine, as it produces noticeable improvements within hours or days compared to the slower response of traditional antidepressant medications, is propelling the growth of the market. In addition, the rising mental health awareness is leading to the growing demand for innovative treatment options. Ketamine clinics, with their potential to address conditions like depression, anxiety, and PTSD, are providing solutions to the mental health crisis in the country. In line with this, ongoing research and clinical trials are validating therapeutic benefits of ketamine. As a result, healthcare professionals in the U.S. are becoming increasingly interested in incorporating ketamine treatments into their practices. Moreover, the rising number of people who do not respond well to traditional psychiatric medications is catalyzing the demand for ketamine treatment that offers benefits to those with treatment-resistant conditions. Additionally, the increasing awareness among the masses about the benefits of ketamine treatment is offering lucrative growth opportunities to industry investors operating in the U.S.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C

What Is Included In Market Segmentation?

The report has segmented the market into the following categories:

Breakup by Treatment:
• Depression
• Anxiety
• PTSD
• Others

Breakup by Therapy:
• On-Site Therapy
• Online Therapy

Breakup by Region:
• Northeast
• Midwest
• South
• West

The report provides a comprehensive analysis of the industry key players listed below:
• Better U LLC
• Field Trip Health and Wellness Ltd.
• Innerwell
• Ketamine Clinics Los Angeles
• Klarisana - Ketamine Treatment Austin
• Klarity Clinic
• Mindbloom Inc.
• Nue Life Health PBC
• NY Ketamine Infusions
• Vitalitas Denver

Key highlights of the Report:

Market Performance (2018-2023)
Market Outlook (2023-2028)
COVID-19 Impact on the Market
Porter's Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape

TOC for the Report:

Preface
Scope and Methodology
Executive Summary
Introduction
SWOT Analysis
Value Chain Analysis
Price Analysis
Competitive Landscape

Explore More Reports:
India Pet Food Market Report: https://www.imarcgroup.com/india-pet-food-market

India Private Equity Market Report: https://www.imarcgroup.com/india-private-equity-market

India Rice Market Report: https://www.imarcgroup.com/india-rice-market

India Security Market Report: https://www.imarcgroup.com/india-security-market

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Ketamine Clinics Market: Key Players and Competitive Landscape 2023-2028 here

News-ID: 3306669 • Views:

More Releases from IMARC Group

Top 15 Leading Commercial Refrigeration Manufacturers in The World 2024
Top 15 Leading Commercial Refrigeration Manufacturers in The World 2024
Commercial Refrigeration Companies Top commercial refrigeration companies are investing in research and development (R&D) to introduce advanced products that offer enhanced efficiency, better temperature management, and reduced environmental impact. Additionally, companies are integrating internet of things (IoT) technology to allow for real-time monitoring and management of refrigeration systems, which helps in reducing operational costs and improving food safety by maintaining optimal conditions. Key players are developing systems that use less power
Top Generative AI Companies in The World 2024
Top Generative AI Companies in The World 2024
Global Generative AI Companies Generative artificial intelligence (AI), also known as generative adversarial networks (GANs) or generative models, works by learning the patterns and features of a dataset and then generating new data instances that resemble the original data. It can create new content, such as images, videos, text, and music, which can be useful in fields like art, design, and entertainment. It can learn the distribution of normal data and
Vietnam Water Treatment Chemicals Market Share, Demand, Industry Growth And Forecast 2024-2032
Vietnam Water Treatment Chemicals Market Share, Demand, Industry Growth And Fore …
IMARC Group's report titled "Vietnam Water Treatment Chemicals Market Report by Type (Coagulants and Flocculants, Corrosion Inhibitors, Scale Inhibitors, Biocides and Disinfectants, Chelating Agents, Anti-Foaming Agents, PH Adjusters and Stabilizers, and Others), End User (Municipal, Power, Oil and Gas, Mining, Chemicals, Food and Beverage, Pulp and Paper, and Others), and Region 2024-2032" Vietnam water treatment chemicals market is projected to exhibit a growth rate (CAGR) of 4.99% during 2024-2032. The Vietnam water
Furniture Market Size, Sales Revenue, Industry Growth, Forecast 2024-2032
Furniture Market Size, Sales Revenue, Industry Growth, Forecast 2024-2032
IMARC Group, a leading market research company, has recently releases report titled "Furniture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032" The global furniture market size reached US$ 660.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 701.7 Billion by 2032. Request For Sample Copy of Report For More Detailed Market insight: https://www.imarcgroup.com/furniture-market/requestsample Factors Affecting the Growth of the Furniture Industry: Rapid Urbanization: Urban areas are leading

All 5 Releases


More Releases for Ketamine

Ketamine Market 2022 Emerging Players, Growth Analysis and Precise Outlook | Seq …
The Global Ketamine Market report focuses on a comprehensive analysis of the recent and future prospects of the Ketamine industry. An in-depth analysis of historical trends, future trends, SWOT analysis, demographics, industrial advances, and regulatory requirements for the market has been performed to analyze the growth rate of each segment and sub-segment. The growth of the Ketamine market was essentially driven by the increasing R&D spending across the world. The
07-14-2021 | Health & Medicine
Fact.MR
Rising Demographic Trends In Elderly Population Boost Injectable Ketamine Market …
The Recent study by Fact.MR- (leading business and competitive intelligence provider) On global Injectable Ketamine market Survey study presents an all in all compilation of the historical, current and future outlook of Injectable Ketamine market as well as the factors responsible for such a Injectable Ketamine Market growth. The report on the market survey of Injectable Ketamine gives estimations of the Size of Injectable Ketamine Market and the overall share of
U.S. Psychedelic Drugs Market 2021| Industry Size, Share, Demand, Manufacturers …
U.S. Psychedelic Drugs Market research analysis report starts with a basic introduction of the 2021 market segmentation, future scenario, Industry growth rate, and industrial opportunities to 2028. The company profile section has parameters such as company synopsis, commercial synopsis, work strategy and planning, SWOT analysis, and present developments. With the study of competitor analysis, the Industry can get the know-how of the strategies of key players in the market that
Psychedelic Drugs Market By top key Players are Phencyclidine, Gamma Hydroxybuty …
One of the utmost and quickest ways to collect information for the business in this fast-paced industry is Psychedelic Drugs Market research or secondary research. This Psychedelic Drugs Market research report makes available state-of-the-art information about the entire market along with the holistic view of the market. It also assesses the Psychedelic Drugs Market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors
Increasing Trend of Onsite Clinic Market 2019 Trend and Forecast with Top Player …
Onsite Clinic Market: Employers are looking for ways to reduce their associated costs while maintaining a healthy workforce, and field clinics are a useful resource for managing chronic diseases and promoting good health. On-site health clinics are evolving to address these and other challenges faced by employers seeking to support a healthy workforce while reducing health care costs. According to a 2015 survey by Benefits Consultant Mercer, nearly 30% of companies
New Detailed Review of Oral Ketamine for Depression Published in JCP
Memphis, TN (April 16, 2019) – A review article published today in The Journal of Clinical Psychiatry indicates that orally administered ketamine is efficacious for depression but may take longer to yield results. The review, authored by Joshua D. Rosenblat and colleagues at the University of Toronto, analyzed 13 articles, including 2 randomized controlled trials (RCTs). The RCTs demonstrated antidepressant efficacy and good tolerability for oral ketamine, but significant changes